Weekly News

Venture Category: Biotechnology


This week's biotechnology venture startup news



AiVita Biomedical - AIVITA Biomedical Closes $25 Million Financing Round (Dec 29 2020)

    Ariel Precision Medicine - What is a Polygenic Risk Score? (Dec 28 2020)
    IntroductionIf you or someone you know is considering genetic testing, you may encounter some new and unfamiliar terms. Most genetic tests ordered through a healthcare provider look for rare, or uncommon changes in your DNA (genetic variants) that may cause single-gene diseases. However, most dis...
      BioAffinity Technologies - Dr. David Elzi Presents Poster at Cell Bio Virtual 2020 (Dec 29 2020)
      Meso-tetra (4-carboxyphenyl) porphyrin (TCPP) is incorporated into cancer cells by the CD320 receptor and clathrin mediated endocytosis Poster Presented December 14, 2020, 1:00 PM – 1:45 PM Authors D. J. Elzi, W. E. Bauta, J. R. Sanchez, S. Mogare, T. Das, P. Zannes-Fatland, V. I. Rebel bioAff...
        BioSapien Inc - New Use for Platelet-rich Plasma in Plastic Surgery (Dec 28 2020)
        The post New Use for Platelet-rich Plasma in Plastic Surgery appeared first on Conduct Science.
        
          Embark - Embark’s Most Popular Dog Names of 2020 (Dec 31 2020)
          The pandemic pet boom had some serious bark. Many pup parents joined Embark Vet to discover more about their new best friends, bringing us closer to realizing our goal of ending preventable disease in dogs.  We took a look at all the dogs we tested who were born in 2020 so we could share the...
            Empirico - Laboratory Assistant (Temporary, Part-Time) (Dec 28 2020)
            Position Title: Laboratory Assistant (Temporary, Part-Time) Location: Madison, WI Position Description: Empirico, a human genetics-focused biotechnology company, is looking for a laboratory assistant to help with routine laboratory operations. This is an excellent opportunity to gain hands-on exp...
              Just Bio Fiber - Just BioFiber wins Pitch Contest (Dec 27 2020)
              “You’re funded!” Emerge Pitch Contest Emerge is thrilled to announce a reprise of the hugely successful cannabis investment “Pitch Contest” in partnership with the industry’s largest cannabis business social network, Leafwire, and cannabis sustainability fund, Regennabis. Select executiv...
                Keriton - What’s In A Label? (Dec 29 2020)
                The answer should be everything. Everything that is needed to complete one’s feeding task safely and timely. But how can all the information that is recommended live ON a bottle label? Infant and Pediatric Feedings: Guidelines for Preparation of Human Milk and Formula in Health Care Facilities...
                  Molecular Assemblies - Senior Microfluidics Engineer (Dec 26 2020)
                  Molecular Assemblies is a San Diego-based company developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products in industrial synthetic biology, personalized therapeutics, precision diagnostics, and eventually information storage, nanotechnology and more. The Sen...
                    Nimbus Therapeutics - Nimbus Therapeutics Regains Worldwide Rights to HPK1 Inhibitor Program from Bristol Myers Squibb (Dec 31 2020)
                    – Supported by positive preclinical data, Nimbus will pursue IND submission for HPK1 inhibitor candidate in 2021 – CAMBRIDGE, Mass. – Dec. 30, 2020 – Nimbus Therapeutics, a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, ...
                      Nurix - Manager/Sr. Manager Cell Therapy Logistics (Dec 28 2020)
                      Nurix Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. Leveraging Nurix’s extensive expertise in E3 liga...
                        Nurix - Gilead and Nurix Establish Strategic Collaboration to Develop Novel Therapies for Cancer and Other Diseases (Dec 28 2020)
                        — Collaboration will Leverage Nurix’s Proprietary Drug Discovery Platform to Identify Novel Agents that Induce Degradation of Specified Drug Targets — FOSTER CITY, Calif. & SAN FRANCISCO–(BUSINESS WIRE)–Jun. 19, 2019– Gilead Sciences, Inc. (...
                          Visikol - High Content Screening for Immune Modulators (Jan 01 2021)
                          Cancer immunotherapies that target T cells via the blockage of immune checkpoints are a promising approach for cancer treatment. However, the response rates vary between cancer patients. Studies have shown that while immunotherapies work well for some cancer patients, other patients fail to respond ...
                            Visional Commerce - High Content Screening for Immune Modulators (Jan 01 2021)
                            Cancer immunotherapies that target T cells via the blockage of immune checkpoints are a promising approach for cancer treatment. However, the response rates vary between cancer patients. Studies have shown that while immunotherapies work well for some cancer patients, other patients fail to respond ...